Ishwaria Subbiah was named executive director of cancer care equity and professional wellness at Sarah Cannon Research Institute. In this role, Subbiah will focus on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over 1,300 physicians at over 250 locations in 24 states across the U.S.
Thyme Care announced the close of a $95 million capital raise. With $55 million in equity funding, Thyme Care welcomes new investor Concord Health Partners with participation from all existing investors, including CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures, and Foresite Capital.
